We catch up with Professor Jan Kirschner!
Gene therapy for childhood onset disability from neuromuscular disorders: What lessons have you learned from gene therapy in neuromuscular disorders, and how do you see this approach evolving in the future?
Another brilliant interview with researchers from EACD / IAACD 2025 at Heidelberg Germany!
